Evidence map›Paper›PMID 41775876›Full record

ArticleScientific reports2026

Enhancing logistic regression classification: insights from simulation and real-world applications through ranked set sampling.

Razieh Yousefi, Benoit Liquet, Mahdi Mahdizadeh, Leili Tapak, Hassan Doosti, Habibollah Esmaily

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Razieh YousefiStudent Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
Benoit LiquetLaboratory of Mathematics and Its Applications de Pau, UMR CNRS-5142, Pau, France.
Mahdi MahdizadehDepartment of Statistics, Hakim Sabzevari University, Sabzevar, Iran.
Leili TapakDepartment of Biostatistics, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran.
Hassan DoostiSchool of Mathematical and Physical Sciences, Macquarie University, Sydney, Australia. hassan.doosti@mq.edu.au.
Habibollah EsmailySocial Determinants of Health Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. esmailyh@mums.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Machine learning algorithms are widely used for disease prediction, but the choice of sampling method is a factor that affects model performance, particularly in large populations, limitations on the availability of resources, and imbalanced datasets, which is common in healthcare research. Ranked set sampling (RSS) offers a more efficient alternative to simple random sampling (SRS) when precise measurement requires great effort and determination, yet ranking sampling units is achievable. In this study, logistic regression (LR) is employed as the most commonly used model in machine learning, and its performance is evaluated under RSS and extreme ranked set sampling (ERSS). We conducted a comprehensive comparison based on a simulation study to evaluate the performance of LR under RSS, ERSS, and SRS across different population sizes, sample sizes, and class imbalance ratios. Set size and correlation between the response variable and the concomitant variable, which is used for ranking, were two key sampling design characteristics examined in RSS and ERSS. The models’ effectiveness was assessed through several standard metrics. Furthermore, the approaches were tested on two practical datasets: one focused on predicting osteoporosis, and the other on assessing maternal health risks. ERSS generally performed better than SRS and RSS, particularly in small or imbalanced datasets, with the advantage becoming more pronounced as the set size (k) increased. When [CDATA[k = 3]], the methods performed similarly. When [CDATA[k = 5]], ERSS often outperformed the other methods, and when [CDATA[k = 10]], ERSS performed best in most scenarios and its metrics achieved higher than 0.95 in most scenarios. With an increase in sample size, the performance of all models improved, but ERSS still exhibited the best performance. On the other hand, ERSS also demonstrated decent performance at small sample sizes based on most metrics. The change in population size did not have a substantial impact on the results. Despite this good performance of ERSS, RSS often exhibited similar performance compared to SRS. In the osteoporosis dataset, ERSS had better LR performance when [CDATA[k=5]] or 10. In the maternal health risk dataset, ERSS improved LR performance, especially when sampling was based on a concomitant variable with higher correlation, validating the simulation findings and demonstrating the practical benefits of rank-based methods. The findings indicated that RSS provided comparable performance to SRS in certain conditions. But, ERSS was highly beneficial compared to SRS and RSS in terms of achieving higher performance metrics. It achieved better performance in both balanced and imbalanced situations, and also with limited sample sizes. Its robustness and efficiency make it a valuable tool in different studies. However, these findings should be used considering the study’s limitations, such as constraints in evaluating extreme imbalance scenarios (e.g., when the correlation coefficient is less than 0.1) and the evaluation of just RSS and ERSS designs. Real-world datasets have also confirmed ERSS’s ability to improve LR’s performance, consistent with simulation results. Overall, our findings indicated that rank-based sampling methods produce results that are at least as favorable as those of SRS, and, given suitable settings, can improve classification performance.

Indexed as

ClassificationExtreme ranked set samplingLogistic regressionRanked set samplingSimple random sampling

Identifiers

PMID41775876
PMCPMC13068937

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.